BR112022025221A2 - Sistemas de expressão de baculovírus - Google Patents

Sistemas de expressão de baculovírus

Info

Publication number
BR112022025221A2
BR112022025221A2 BR112022025221A BR112022025221A BR112022025221A2 BR 112022025221 A2 BR112022025221 A2 BR 112022025221A2 BR 112022025221 A BR112022025221 A BR 112022025221A BR 112022025221 A BR112022025221 A BR 112022025221A BR 112022025221 A2 BR112022025221 A2 BR 112022025221A2
Authority
BR
Brazil
Prior art keywords
expression systems
baculovirus expression
compositions
anellovirus
orf1
Prior art date
Application number
BR112022025221A
Other languages
English (en)
Portuguese (pt)
Inventor
Delagrave Simon
David Pitts Jared
Original Assignee
Flagship Pioneering Innovations V Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Innovations V Inc filed Critical Flagship Pioneering Innovations V Inc
Publication of BR112022025221A2 publication Critical patent/BR112022025221A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14044—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/00041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR112022025221A 2020-06-12 2021-06-11 Sistemas de expressão de baculovírus BR112022025221A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063038603P 2020-06-12 2020-06-12
US202163147056P 2021-02-08 2021-02-08
PCT/US2021/037076 WO2021252943A2 (en) 2020-06-12 2021-06-11 Baculovirus expression systems

Publications (1)

Publication Number Publication Date
BR112022025221A2 true BR112022025221A2 (pt) 2023-03-07

Family

ID=78845950

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022025221A BR112022025221A2 (pt) 2020-06-12 2021-06-11 Sistemas de expressão de baculovírus

Country Status (12)

Country Link
US (1) US20230340527A1 (cg-RX-API-DMAC10.html)
EP (1) EP4164667A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023530277A (cg-RX-API-DMAC10.html)
KR (1) KR20230036109A (cg-RX-API-DMAC10.html)
CN (1) CN116034160A (cg-RX-API-DMAC10.html)
AU (1) AU2021288051A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022025221A2 (cg-RX-API-DMAC10.html)
CA (1) CA3186872A1 (cg-RX-API-DMAC10.html)
IL (1) IL298906A (cg-RX-API-DMAC10.html)
MX (1) MX2022015801A (cg-RX-API-DMAC10.html)
TW (1) TW202239762A (cg-RX-API-DMAC10.html)
WO (1) WO2021252943A2 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3121528A1 (en) 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes and methods of use
CA3206361A1 (en) * 2020-12-23 2022-06-30 Flagship Pioneering Innovations V, Inc. In vitro assembly of anellovirus capsids enclosing rna
WO2022170195A1 (en) * 2021-02-08 2022-08-11 Flagship Pioneering Innovations V, Inc. Hybrid aav-anellovectors
TW202334423A (zh) 2021-12-15 2023-09-01 美商旗艦先鋒創新公司 表面經修飾之病毒顆粒及模組化之病毒顆粒
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送
CN117305365B (zh) * 2023-11-28 2024-03-19 中国科学院生物物理研究所 昆虫细胞—哺乳动物细胞表达穿梭载体SmartBM-1及其应用
WO2025160409A1 (en) 2024-01-26 2025-07-31 Flagship Pioneering Innovations V, Inc. Viral vectors for modulating vegf function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011046634A1 (en) * 2009-10-16 2011-04-21 Pfizer, Inc. Infectious clones of torque teno virus
KR101320192B1 (ko) * 2008-10-16 2013-10-30 조에티스 엘엘씨 토크 테노 바이러스(ttv) 분리물 및 조성물
RU2553223C2 (ru) * 2009-08-21 2015-06-10 Виргиния Тек Интеллекчуал Пропертиз, Инк. ВАКЦИНЫ НА ОСНОВЕ СВИНОГО ВИРУСА Torque teNO И СПОСОБЫ ДИАГНОСТИКИ ИНФЕКЦИЙ, ВЫЗВАННЫХ ЭТИМ ВИРУСОМ
CA3066750A1 (en) * 2017-06-13 2018-12-20 Flagship Pioneering Innovations V, Inc. Compositions comprising curons and uses thereof

Also Published As

Publication number Publication date
TW202239762A (zh) 2022-10-16
CN116034160A (zh) 2023-04-28
CA3186872A1 (en) 2021-12-16
EP4164667A2 (en) 2023-04-19
WO2021252943A3 (en) 2022-01-20
KR20230036109A (ko) 2023-03-14
EP4164667A4 (en) 2024-10-23
JP2023530277A (ja) 2023-07-14
IL298906A (en) 2023-02-01
AU2021288051A1 (en) 2023-01-19
US20230340527A1 (en) 2023-10-26
WO2021252943A2 (en) 2021-12-16
MX2022015801A (es) 2023-05-19

Similar Documents

Publication Publication Date Title
MX2021013581A (es) Composiciones de nanoemulsiones que comprenden ingredientes biologicamente activos.
BR112023023105A2 (pt) Formas cristalinas de 5-fluoro-4-imino-3-metil-1-tosil-3,4-di-hidropirimidin-2-ona, e misturas, composições e métodos de uso das mesmas
CO2021008980A2 (es) Sistemas activos dinámicos acromosómicos
CO2023018064A2 (es) Anticuerpos anti-ccr8 y usos de los mismos
MX2020012765A (es) Métodos y compuestos de ácido nucleico modificado con lípidos.
AR113031A1 (es) Composiciones de nanopartículas lipídicas (lnp) que comprende arn
CL2021001276A1 (es) Dispositivos y sistemas de difusión microfluídica y métodos de fabricación y uso de estos (divisional de la solicitud n° 201902831)
WO2021252943A3 (en) Baculovirus expression systems
BRPI0816636A2 (pt) membranas microporosas que têm um tamanho médio de poro relativamente grande e métodos para a produção das mesmas
CL2024000642A1 (es) Anticuerpos del receptor antitransferrina y usos de los mismos
PY1800237A (es) Aislados de bacillus y usos de los mismos
BR0208076A (pt) Células t cd4*cd25* reguladoras de sangue humano
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
MX2019003406A (es) Estructuras de nonofibra y metodos de uso de las mismas.
CU20210041A7 (es) Péptidos inmunogénicos con motivos de oxidorreductasa
UY32812A (es) Anticuerpos humanos de alta afinidad para angiopoyetina -2 humana.
AR107967A1 (es) Ácido hialurónico modificado, método para su preparación y usos del mismo
BR112018075185A2 (pt) formulações análogas de hidróxi metionina adequadas para aplicações de produtos químicos especializados
BR112019000693A2 (pt) composições de muc1- car e métodos para uso
BRPI0820043A8 (pt) Atividades do receptor de vitamina d e seus usos
CR20160392A (es) Proteínas de fusión tatk-cdkl5, composiciones, formulaciones y uso de esta
BR112017016897A2 (pt) cepas fúngicas e métodos de uso
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
BR112018012152A2 (pt) redes polímeras tridimensionais com canais situados nelas
CO2021010786A2 (es) Toxinas apxia, apxiia y apxiiia inactivadas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.